chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I administered the imz to pt & then told pt to wait in designated waiting area for 15 minutes.  During that time, the woman accompanying the pt started yelling that she needed help.  I was on the phone with another pt & in the time it took me to put that pt on hold, my certified immunizing tech responded to pt.  The pt had slummed over to the floor & had fainted.  I responded immediately after putting telephone customer on hold.  I told my staff to call 911, had the tech bring me the emergency kit and paged management.  I checked the pt's pulse and he immediately came to.  He was clammy all over and pale in color, but his color came back to him quickly.  After making sure he was ok, I sat the pt upright and gave him a few sips of water and a cool compress.  He then moved himself to a bench and then a chair.  EMS and management responded.  The pt insisted that he was fine, but reluctantly let EMS check his blood pressure and management do their report.  He was cleared and left on his own.
Symptoms patient had were fever, chills, muscle cramping, headache, and sore throat; symptoms lasted 1 week.
After I received the vax, I started out with redness, swelling and pain at the site. This started the day of my vaccine. Progressed more swelling, redness, then to arm pain, neck and back pain. Now causing dysfunction of left arm. I am still having these symptoms.
I have been having extreme insomnia. I have been trying prescribed and over the counter medications. As soon as the medications wear off, I immediately wake up from my sleep. I went the doctor, and they did blood work and other tests. I am still waiting on the results.
Pt developed a papular rash and severe body aches the next day with throbbing headache and s/sx's of mild meningitis with phono and photophobia. also with drenching sweats and tactile fevers.
Severe hives, itching, spreading of hives, pain, discomfort all over, severe itching under arms, tops and bottoms of feet, torso and groin region.
Slept for three to four days after second shot; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Slept for three to four days after second shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERSOMNIA (Slept for three to four days after second shot). At the time of the report, HYPERSOMNIA (Slept for three to four days after second shot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Information has been received from a registered nurse concerning a 19 year old female who on 20 Mar-2007 was vaccinated with a 0.5 ml dose of Gardasil vaccine (yeast) (lot # 656051/0244U). Concomitant medication included ethinyl estradiol (+) norethindrone acetate "1/20 BCP's." On 20-MAR-2007 the patient fainted after receiving a shot of the vaccine. The patient laid down, smelling salt used and was given juice and a granola bar. The patient had not eaten since the night before. Subsequently, the patient recovered in less than 5 minutes. No product quality complaint was involved. Additional information has been requested.
Vaccine was stored in refrigerator on 4-Jun-2022 and was administered on 23-Jul-2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 4-Jun-2022 and was administered on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 4-Jun-2022 and was administered on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 4-Jun-2022 and was administered on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 4-Jun-2022 and was administered on 23-Jul-2022).    No concomitant medications was reported. The patient received half dose of Moderna vaccine. They administered the vaccine to 346 patients after the 30 days by used and total Number of vials was 35. The vial did not undergo any temperature excursions. The vial was initially stored in the refrigerator on 04-Jun-2022 and 35 vials were affected. No treatment medications was reported.
Patient experiences throbbing headache, body aches and nausea.  CT head is within normal limits.  Patient is treated with IV fluids, IV acetaminophen and ondansetron.
Developed chills, headache and body aches with severe fatigue the morning following the vaccine.  Took Tylenol every 4 hours and slept. Symptoms were gone 24 hours later, the next day.
Starting from midnight, i experienced fever and body aches. In am i had extreme dizziness and vomited.  I also experienced extreme weakness. Fever continued past following midnight. Stomach upset was noted. Following day i still experienced extreme fatigue and weakness.
Patient developed hives. Vitals checked every 10 minutes and hives resolved prior to patient leaving facility. Hives were located on patient right leg where MMR was administered.
weakness in the right arm, but mainly in the hand and cannot grasp on anything; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (weakness in the right arm, but mainly in the hand and cannot grasp on anything) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced MUSCULAR WEAKNESS (weakness in the right arm, but mainly in the hand and cannot grasp on anything). At the time of the report, MUSCULAR WEAKNESS (weakness in the right arm, but mainly in the hand and cannot grasp on anything) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.
Narrative:  91yo patient died on 9/27/21. Last note in records from PCC on 7/1/2021 stating "Patient is a 80yo MALE here to reestablish care. he was in a near fatal MVA last year and suffered lumbar vertebral fx which resulted in nerve damage. he has neuropathy and bowel/bladder incontinence. he was placed in a NH after the accident... CURRENT PROBLEM LIST: Cerebral aneurysm, nonruptured (ICD-9-CMAllergies (ICD-9-CM 995.3) Hyperlipidemia (SCT 55822004) Acquired sensorineural hearing loss (SCT 609125008) Erectile dysfunction (SCT 397803000) Ulcerative Colitis (ICD-9-CM 556.9) Hiatal hernia (ICD-9-CM 553.3) Arthritis, Rheumatoid (ICD-9-CM 714.0) Subjective tinnitus (ICD-9-CM 388.31) Carcinoma of prostate (SCT 254900004) Past Medical History: 1) allergies 2) hearing loss 3) UC 4) RA 5) prostate ca - initially had seed implants, then cryo, last bx was neg about 6 months ago 6) ED 7) HLP 8) cerebral aneurysm 9) a fib - nov 2015 10) cochlear implant in jan 2019" No further info since then regarding circumstances of pt's death. Pt did receive covid vaccines on 4/9/21 & 5/11/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Very bad headache; Extremely tired; Had metallic taste that lasted 24 hours; A spontaneous report was received from a nurse concerning a 42-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced very bad headache, extremely tired, and metallic taste.  The patient's medical history was not provided. Concomitant medication included unspecified birth control.  On 22 Dec 2020, the patient received the first of two planned doses of mRNA-1273 (Lot# 011J20A, Exp. unknown).   On 23 Dec 2020, the patient experienced very bad headache, extremely tired, and metallic taste. It was reported the patient's physician was not aware of the reported events. The patient denied any treatment.   Action taken with mRNA-1273 in response to the reported events was not reported.  The outcome for the events very bad headache, extremely tired and metallic taste considered as recovered/resolved.; Reporter's Comments: This case concerns a 42-year-old female who experienced NS unexpected events of dysgeusia and NS expected events of headache, fatigue.  Event onset occurred 2 days after the first dose of mRNA-1273. No treatment reported. Events resolved. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
I had my period and I bled for 15 days. I have never had a such a long period ever; My sex drive has just depleted and I have no drive; sore arm; hurting me a lot; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (I had my period and I bled for 15 days. I have never had a such a long period ever), LIBIDO DECREASED (My sex drive has just depleted and I have no drive), PAIN IN EXTREMITY (sore arm) and PAIN (hurting me a lot) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot# 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (I had my period and I bled for 15 days. I have never had a such a long period ever), LIBIDO DECREASED (My sex drive has just depleted and I have no drive), PAIN IN EXTREMITY (sore arm) and PAIN (hurting me a lot). At the time of the report, PAIN IN EXTREMITY (sore arm) and PAIN (hurting me a lot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-114650 (Patient Link).
Loss of consciousness, pupils not seen in the eyes. Unresponsiveness, jerking body movements, seizures. Anaphylactic shock. Paleness. Sweat all over body, for 5 minutes. After doctor lied the patients down she was looking in the ceiling lost, loss of concentration, tiredness for 2 days till present, foggy brain.
w/in 1hr of vax pt became weak;throat sore, fever & vomiting began the next day & has cont since;
Approximately 6 hours after receiving the second dose of the Moderna Vaccine on 05/12/2021 I started having chills. This progressed through the night with a fever reaching 104.2F. After taking 750mg of acetaminophen the fever reduced to around 102F. The fever persisted at 102F accompanied by heavy perspiration for approximately 40 hours with 750mg of acetaminophen being taken every 6 hours. For about 10 more hours the fever stayed around 100F with chills and constant perspiration until dehydration set in. Nausea limited the amount of water that could be consumed ultimately resulting in mild dehydration. After fever broke I continue to have headaches through filling out this form along with sharp pains in my lower left leg on the front of the leg. I also have a lot of pain in the upper right glute as if I had been hit my something quite hard. For about 48 hours while these symptoms occurred I remained in bed and tried to drink water. I spoke with the pharmacist who administered the vaccine today and she advised me to report my symptoms right away and to follow up with my doctor on Tuesday or Wednesday if my symptoms persist.
Pt stated later  in eve. after shots her right arm was red, tight, and warm to touch. Appeared to have "red bord around arm about 2" below injection site" went to urgent care - Given ATARAX and CIPRO
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. It was reported that patient's facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger that caller was unable to download were for the months of Dec-2021, Jan-2022, and Feb-2022. The reporter also stated that no adverse reactions were reported by any patients. No Treatment information was reported.
Went to sit in waiting area 15 seconds after vaccine injection. While sitting, about 2 minutes later began feeling light-headed, got up and walked to pharmacy counter to notify pharmacy tech about symptom and fainted a few seconds later. Woke up on the floor shortly after and had my bp checked, was about 82/35, shaking, sweating and felt weak. Several minutes later emergency medics checked vitals, bp was up to over 100 sys, oxygen normal and blood sugar 97. Felt light-headed for about 20-30 minutes later. Drove home about 45  minutes after receiving shot.
muscle aches; chills; diarrhea; nausea; vomiting; This is a spontaneous report from a contactable physician. A 29-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly on 23Dec2020 at single dose for COVID-19 immunization in hospital. Medical history was reported as none, no known allergies.  The patient's concomitant medications within 2 weeks of vaccination was reported as none.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced diarrhea started from day after vaccine (24Dec2020) then nausea vomiting. Patient's diarrhea has resolved but 2 days after vaccine (25Dec2020) patient continues to have vomiting, muscle aches and chills. No treatment received for the adverse events. The outcome of diarrhea was recovered in Dec2020, of the other events was not recovered. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19. It was not reported as serious.  The information on the batch number has been requested.
Patient received the first dose of Moderna vaccine on 7/25/21 at about 3:00 pm. That night she experienced severe left breast pain including a rash from the nipple and top of her breast to under her armpit. She stated it felt like mastitis. After 3-5 days she observed a caramel color discharge from the left breast. When compressed her breast would discharge this caramel color. Once she received her second dose in the series on 8/22/21, she reports having blood discharge from the same breast. Even now she can get some blood to discharge from her breast if compressed.
c/o dizziness after receiving vaccine. Given PO fluids and crackers. Felt better and d/c'ed home.
Started experiencing severe back pain the day before I was due for my second dose of the COVID 19 Pfizer shot. The nurse recommended I hold off on my second shot until I felt better (seemed like a possible kidney stone). Beginning early in the morning of May 31st I started experiencing severe leg pain and a very swollen leg. Went to the emergency room at 4am. Doctors discovered multiple clots in my leg and abdomen. The abdominal clot was 8mm long. I had low platelets and blood work was not good. Was in the ICU for 5 days trying to stabilize. Was released after almost 2 weeks.
pt recvd vax pt went to president's inauguration & later asked were was & why was there; did not remember being in Washington; EEG showed focal spikes & MRI showed mild prominence of the pituitary gland;
Information has been received from a physician concerning a male who had never been immunized or had never developed wildtype varicella in the past and was exposed to his niece who developed varicella wildtype breakthrough.  After exposure, the patient was subsequently vaccinated with a dose of varicella virus vaccine live and still developed the wildtype infection.  Unspecified medical attention was sought.  The patient's nephew also developed an adverse event after vaccination with varicella virus vaccine live.  Additional information has been requested.
Week after vaccine, injection site became swollen, sore, red and itchy, stayed that way from Feb 9th  through Feb 28th.  Today March 3rd, still a little sore, second Covid vaccine scheduled for March 5th.   Correction, first  vaccine was on Feb 3, 2021
Sweats; chills; Fever; Fatigued; Difficulty breathing which comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing which comes and goes), HYPERHIDROSIS (Sweats), CHILLS (chills), PYREXIA (Fever) and FATIGUE (Fatigued) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Difficulty breathing which comes and goes), HYPERHIDROSIS (Sweats), CHILLS (chills), PYREXIA (Fever) and FATIGUE (Fatigued). The patient was treated with GUAIFENESIN (MUCINEX) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Difficulty breathing which comes and goes), HYPERHIDROSIS (Sweats), CHILLS (chills), PYREXIA (Fever) and FATIGUE (Fatigued) outcome was unknown.            Treatment Medication includes: Steroid Inhaler (Device)  Action taken with mRNA-1273 in response to the event was not applicable.
I was 24 weeks pregnant, my estimated date of delivery is May 9, 2022. I decided to get vaccinated on my break at lunch. Approx. 3 hours after being vaccinated I had a head fog and my ears were hot and red as I was sitting down. I then was taken to see my charge registered nurse who took my blood pressure and it was 149/100 while laying down. Later that night, I had severe head ache and body aches along with fatigue. I now also have a pain radiating from my left thumb to my forearm which is the side I was vaccinated on. I am right hand dominate and have no issues with my right side.
DTAP, polio and MMR given 3-1-04. Evening of 3-2-04. Mom noticed 4 inch circumference raised red hot area on deltoid right arm.
Severe headache , nausea for fist couple of days. At 1 week Covid arm started. Itch at injection site, dime sized lump that wasn't there previous days, redness. As of today, lump is red and about 3-4 across. Still itchy.
This spontaneous report as received from a 66 year old male patient with cardiovascular disorder (CV), as part of a marketing research program titled "HCC adult vaccine location journey" (project # 15-1340) conducted by the planning shop intl, refers to himself.   On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot# unknown). Concomitant therapy was not reported. On an unknown date the patient experienced soreness at injection site. The outcome of the event was recovered in February 2015. The patient also experienced soreness at injection site after vaccination of PNEUMOVAX23. (captured in MARRS#1510USA013303). This is one of the reports concerning the same patient. Additional information has been requested.
low grade fever; vomiting; dull headache; exhaustion; This is a spontaneous report from a non-contactable consumer (Patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose2, single for Covid-19 immunization. Patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 30July2021 as dose1, single for Covid-19 immunization and experienced Sore arm. Patient was not diagnosed with Covid-19 Prior to vaccination. It was reported as after second shot had a low grade fever and vomiting. For whole next day had a dull headache and exhaustion. Since the vaccination patient was not tested for Covid-19. The patient underwent lab tests and procedures which included body temperature: low grade fever. The outcome for the events was reported as resolved on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Hives, sore eyes, aches, headache, itching, fatigue, dizzy, sore throat, swollen face, weakness, chills.
Breakthrough admission after three vaccines Moderna 1/27/21 Lot# 302H20A;  Moderna 2/25/21 Lot# 011M20A;  Moderna 11/17/21 Lot# 051F21A
devel edema of feet w/in 24 hrs; fine rash, fever 90.5-92; hx for DPH given x 24 hr;